Impact BioMedical, INC. Other Current Liabilities
Impact BioMedical, INC. (IBO) had Other Current Liabilities of $1.33 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Current $1.33M.
- 2026-03-31: Other Liabilities, Current $1.10M.
- 2025-12-31: Other Liabilities, Current $621.00K.
- 2024-12-31: Other Liabilities, Current $399.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $1.33M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $621.00K 10-Q · filed 2026-08-07 |
| 2024-12-31 | $399.00K 10-K · filed 2026-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |